Review Article
The Development of Critical Care Medicine in China: From SARS to COVID-19 Pandemic
Table 3
The number of confirmed cases and mortality rate of SARS and COVID-19 [
14,
16].
| Region | Confirmed cases | Mortality rate | SARS | COVID-19 | SARS (%) | COVID-19 (%) |
| Eastern | Beijing | 2,521 | 593 | 7.656 | 1.518 | Tianjin | 175 | 190 | 8.000 | 1.579 | Hebei | 215 | 328 | 5.581 | 1.829 | Liaoning | 7 | 146 | 28.571 | 1.370 | Shanghai | 8 | 656 | 25.000 | 1.067 | Jiangsu | 7 | 653 | 0.000 | 0.000 | Zhejiang | 4 | 1,268 | 25.000 | 0.079 | Fujian | 3 | 356 | 0.000 | 0.281 | Shandong | 1 | 788 | 0.000 | 0.888 | Guangdong | 1,512 | 1,588 | 3.836 | 0.504 | Hainan | 0 | 168 | — | 3.571 | Total | 4,453 | 6,734 | 6.330 | 0.743 |
| Western | Inner Mongolia | 282 | 201 | 9.929 | 0.498 | Chongqing | 3 | 579 | 0.000 | 1.036 | Guangxi | 22 | 254 | 13.636 | 0.787 | Sichuan | 20 | 561 | 10.000 | 0.535 | Guizhou | 0 | 147 | — | 1.361 | Yunnan | 0 | 185 | — | 1.081 | Tibet | 0 | 1 | — | 0.000 | Shaanxi | 12 | 306 | 0.000 | 0.980 | Gansu | 8 | 139 | 12.500 | 1.439 | Qinghai | 0 | 18 | — | 0.000 | Ningxia | 5 | 75 | 20.000 | 0.000 | Xinjiang | 0 | 76 | — | 3.947 | Total | 352 | 2,542 | 9.943 | 0.944 |
| Central | Shanxi | 448 | 198 | 5.357 | 0.000 | Jilin | 35 | 112 | 17.143 | 0.893 | Heilongjiang | 0 | 944 | — | 1.377 | Anhui | 10 | 991 | 0.000 | 0.605 | Jiangxi | 1 | 937 | 0.000 | 0.107 | Henan | 15 | 1,276 | 0.000 | 1.724 | Hunan | 6 | 1,019 | 16.667 | 0.393 | Hubei | 7 | 68,128 | 14.286 | 6.623 | Total | 522 | 73,605 | 6.130 | 6.194 |
|
|